DempoChem Logo
  1. HomeHome
  2. /ProductsProducts
  3. /Bioactive CompoundsBioactive Compounds
  4. /JAK/STAT SignalingJAK/STAT Signaling
  5. /EGFREGFR
  6. /PruvonertinibPruvonertinib
Chemical structure of CAS 2064269-82-3

Pruvonertinib

In Stock•Starting at $658 for 1 mg•Purity ≥ 99.5%
CAS No.2064269-82-3
MDL No.N/A
MFC27H32N8O2
MW500.60
InChI KeyOEFWUILIMFIVSE-UHFFFAOYSA-N
CUSTOM SYNTHESIS

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
1 mg99.50%$658In Stock
5 mg99.50%$1629In Stock
10 mg99.50%$2750In Stock
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.2064269-82-3
Product NamePruvonertinib
Heavy Atom Count37Rotatable Bond Count10
Atom Stereo Count0Bond Stereo Count0
HBA9HBD2
TPSA99.920 ŲCharge0
Exact Mass500.26482Complexity1429.45
pKa5.875XLogP3.974

Related Articles

Studies related to this compound and its mechanism of action

Discovery of YK-029A, a novel mutant EGFR inhibitor targeting both T790 M and exon 20 insertion mutations, as a treatment for NSCLC.

European journal of medicinal chemistry • Vol. 258 • 2023
PMID: 37406381DOI: 10.1016/j.ejmech.2023.115590

Documentation

Similar Products

  • Osimertinib

    CAS No.1421373-65-0

  • Aumolertinib

    CAS No.1899921-05-1

  • Aumolertinib Mesylate

    CAS No.2134096-06-1

  • Befotertinib

    CAS No.1835667-63-4

  • Oritinib

    CAS No.2035089-28-0

  • N-[2-[2-(dimethylamino)ethyl-methylamino]-4-methoxy-5-[[4-(5-methoxypyrrolo[3,2-b]pyridin-1-yl)pyrimidin-2-yl]amino]phenyl]prop-2-enamide

    CAS No.2050906-40-4

Your Partner for
Complex Chemistry
logo
  • About Us
  • Perspectives
  • Products
  • Contact
  • Preclinical Development
  • Technologies
  • Custom Synthesis
Ready to start your project?

Provide your target molecule or project specifications to align on a tailored development and scale-up pathway with our scientific team.

START A PROJECT
Westerstraat 10, 3016 DH, Rotterdam, The Netherlands
Westerstraat 10, 3016 DH, Rotterdam, The Netherlands
logo

All products are supplied strictly for research and development use only and are not intended for human or veterinary administration, diagnostic use, or therapeutic use. Preclinical and related services are provided solely for research and development purposes and do not constitute clinical diagnosis, treatment, or veterinary care.

©2026 DempoChem. All Rights Reserved.
DHLFedExUPSPostNL
CLIENT PORTAL|TERMS AND CONDITIONS|PRIVACY POLICY|
  • Products
    • CDMO Compounds
    • API & Candidates
  • Services
    CDMO & Manufacturing
    • Custom Synthesis
    • Process Development
    • Lab To Pilot
    • Commercialization
    • Generic APIs
    CRO
    • Preclinical
    • Pharmacology & Efficacy
    • DMPK & Bioanalysis
    • Toxicology & Safety
    • Disease Models
    Technologies
    • High-Potent
    • Chiral Synthesis
    • Cloud Synthesis
    • Fermentation
    • Flow Chemistry
    • Biocatalysis
    Support
    • Regulatory Support
    • Supply Chain Solutions
  • About
  • Perspectives
  • Contact